Skip to content
10-Q

Quarterly Report

INNOVATION1 BIOTECH INC.

0001477932-23-000341

← back to feed
Filed
Jan 17, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Jan 17, 2023 20.02M sh
Current Liabilities Q1 2023 · Nov 30, 2022 $1.91M
Current Liabilities Q1 2023 · Aug 31, 2022 $29.81M
Total Liabilities Q1 2023 · Nov 30, 2022 $2.16M
Total Liabilities Q1 2023 · Aug 31, 2022 $41.11M
Current Assets Q1 2023 · Nov 30, 2022 $120.74K
Current Assets Q1 2023 · Aug 31, 2022 $286.96K
Total Assets Q1 2023 · Nov 30, 2022 $4.25M
Total Assets Q1 2023 · Aug 31, 2022 $43.96M
Eps Basic Q1 2023 · Nov 30, 2022 −$0.04
Eps Basic Q1 2023 · Nov 30, 2021 −$0.04
Rd Expense Q1 2023 · Nov 30, 2021 $0